jueves, 22 de junio de 2017

Cancer Information Highlights, June 22, 2017

Cancer Information Highlights, June 22, 2017

National Cancer Institute

Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
New from NCI
Video—Steps to Find a Clinical Trial
 The new video on this page illustrates how to use our six-step guide to help you find a treatment clinical trial.
HPV Vaccination Linked to Decreased Oral HPV Infections
 New study results suggest that the human papillomavirus (HPV) vaccine may sharply reduce oral HPV infections that are a major risk factor for oropharyngeal cancer, a type of head and neck cancer.
Less Chemotherapy May Be Best Choice for Some Patients with Colon Cancer
nurse bandages chemotherapy patient Recent trial results suggest that a shorter course of chemotherapy following surgery may be enough for patients at low risk of disease recurrence.
PSA Test Fact Sheet Updated

The prostate-specific antigen (PSA) test fact sheet has been revised to reflect the latest guidance from the U.S. Preventive Services Task Force.
Asbestos Exposure and Cancer Risk Fact Sheet Updated

This fact sheet has been updated. Learn what asbestos is and how it relates to the risk for cancer and other diseases.
Clinical Trial Seeks to Determine if Two Targeted Drugs Are Better Than One

This ongoing clinical trial is enrolling patients with newly diagnosed metastatic non-small cell lung cancer that tests positive for a mutation in the EGFR gene. Doctors want to know if combining afatinib with cetuximab improves survival better than afatinib alone for these patients.
FDA Expands Approval of Pembrolizumab for First-Line Treatment of Non-Small Cell Lung Cancer

The Food and Drug Administration (FDA) approved the immune checkpoint inhibitor pembrolizumab to be used with chemotherapy as a first-line treatment for non-small cell lung cancer.
PDQ Summary Updates
Nausea and Vomiting Related to Cancer Treatment

We updated our PDQ summary on cancer-related nausea and vomiting with major revisions to all sections of the summary.
Drug Information Updates
New Approval for Microsatellite Instability-High Cancer

We’ve updated our pembrolizumab drug summary to include a recent approval from FDA. Pembrolizumab is now approved to treat solid tumors with certain genetic features: mismatch repair deficiency and high microsatellite instability. Tumors with these genetic mutations  may not respond to some types of treatment.
Also of Interest

Once people complete cancer treatment, they often face an adjustment period. These pages have information about coping with this transition, planning for follow-up care, and recognizing the physical, emotional, and family issues that may occur.
Fluoridated Water Fact Sheet

This fact sheet, which reviews research about fluoridated water and cancer risk, was recently updated with additional references.
Questions to Ask Your Doctor about Treatment Clinical Trials

Talking with your doctor is an important part of finding a treatment trial that might be right for you. This page has many suggested questions that can help you get the conversation going.

No hay comentarios:

Publicar un comentario